Global
The FDA gave De Novo clearance for AppliedVR's EaseVRx system to help with chronic lower back pain. CEO Matthew Stoudt introduces the technology and talks about what’s next for the digital therapeutic company.
This week's top stories include SCOTUS blocking the Biden Administration vaccination rule for employees of large companies, while upholding a mandate for healthcare workers at facilities that accept Medicare and Medicaid funding, and digital medicine platform Akili plans to go public through merging with SPAC Social Capital Suvretta.
HIMSS21
Robert Cohen, formerly the president of Appriss Health, explains how the company helps payers, providers and patients coordinate behavioral healthcare and overcome challenges.
Virtual technology could broaden access to children’s mental health services, according to Naomi Allen, cofounder and CEO of Brightline.
What's next for SPACs, IPOs and digital health in the year to come? Lee Shapiro, a partner at 7wireVenture, examines the trends.
Regulatory changes are coming for 2022. Christine Moundas, a partner at Ropes and Gray, gives a preview.
This week's top stories include federal agencies issuing an alert amid diplomatic rumblings about Russia and Ukraine from the U.S. government, and decentralized clinical research platform Thread snapping up voice-powered research company inVibe.
The pair will research how aging and the environment impact skin, and develop new digital diagnostic tools for dermatology.
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.
HIMSS21
Artificial intelligence and data analytics have the power to present clinicians with a full picture of patient health, according to Dr. Alan S. Young, head of clinical partnerships at KēlaHealth.